- Home
- ITIC vs EBS Comparison
ITIC vs EBS Comparison
Compare ITIC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITIC | EBS |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.1M | 595.6M |
| IPO Year | 1995 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ITIC | EBS |
|---|---|---|
| Price | $227.81 | $11.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 11.1K | ★ 572.0K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.58% | N/A |
| EPS Growth | 43.49 | ★ 75.76 |
| EPS | ★ 14.59 | 1.89 |
| Revenue | $258,298,000.00 | ★ $1,043,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | $15.79 | ★ $5.83 |
| Revenue Growth | ★ 14.93 | N/A |
| 52 Week Low | $190.20 | $4.02 |
| 52 Week High | $288.98 | $14.06 |
Technical Indicators
Market Signals| Indicator | ITIC | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 48.78 |
| Support Level | $194.68 | $10.51 |
| Resistance Level | $235.03 | $12.43 |
| Average True Range (ATR) | 10.98 | 0.48 |
| MACD | -4.05 | 0.05 |
| Stochastic Oscillator | 26.15 | 73.58 |
Price Performance
Historical ComparisonAbout ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.